SEC Form 4 · accession 0001720702-18-000002
Arcus Biosciences, Inc. · RCUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
David V Goeddel
10% Owner
COLUMN GROUP II, LP
10% Owner
Peter Svennilson
10% Owner
Tim Kutzkey
10% Owner
Column Group II GP, LP
10% Owner
PONOI CAPITAL, LP
10% Owner
Ponoi Management, LLC
10% Owner
Period of report
Mar 19, 2018
Accepted (ET)
Mar 19, 2018 · 2:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001724521
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 19, 2018 | C | 1,767,676 | — | A | 1,767,676 | D | |
| Common StockF1,F2 | Mar 19, 2018 | C | 875,087 | — | A | 2,642,763 | D | |
| Common StockF1,F2 | Mar 19, 2018 | C | 427,660 | — | A | 3,070,423 | D | |
| Common StockF1,F3 | Mar 19, 2018 | C | 470,427 | — | A | 470,427 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF2,F1 | — | Mar 19, 2018 | C | 1,767,676 | D | — | — | Common Stock | 1,767,676 | 0 | D |
| Series B Preferred StockF2,F1 | — | Mar 19, 2018 | C | 875,087 | D | — | — | Common Stock | 2,642,763 | 0 | D |
| Series C Preferred StockF2,F1 | — | Mar 19, 2018 | C | 427,660 | D | — | — | Common Stock | 3,070,423 | 0 | D |
| Series C Preferred StockF3,F1 | — | Mar 19, 2018 | C | 470,427 | D | — | — | Common Stock | 470,427 | 0 | D |
Explanation of responses
- F1Immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A, Series B and Series C preferred stock automatically converted into one share of common stock. The Series A, Series B and Series C preferred stock had no expiration date.
- F2The securities are directly held by The Column Group II, LP ("TCG II") and indirectly held by The Column Group II GP, LP ("TCG II GP") the general partner of TCG II. TCG II GP has voting and dispositive power with respect to these shares. The individual managing partners of TCG II GP are Peter Svennilson and David Goeddel, who may be deemed to have shared voting, investment and dispositive power with respect to these shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares
- F3The securities are directly held by Ponoi Capital, LP ("Ponoi LP") and indirectly held by Ponoi Management, LLC ("Ponoi LLC") the general partner of Ponoi LP. Ponoi LLC has voting and dispositive power with respect to these shares. The individual managing partners of Ponoi LLC are Peter Svennilson, David Goeddel and Tim Kutzkey, who may be deemed to have shared voting, investment and dispositive power with respect to these shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.